| Jennifer Marie Roebuck, DPT | |
|
4016 Laramie St, Cheyenne, WY 82001-2064 | |
| (307) 637-4617 | |
| Not Available |
| Full Name | Jennifer Marie Roebuck |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 4016 Laramie St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518605898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-2171 (Wyoming) | Primary |
| Provider Name | Blair Investments Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912052242 PECOS PAC ID: 9234161035 Enrollment ID: O20050831000989 |
News Archive
Injuries and deaths resulting from medical errors can have profound long-term consequences on patients and families. Seriously harmed patients and/or family members who have lost a loved one may describe feelings of neglect, isolation, fear, anger, and despair, among other emotions, many of which can be heightened by organizational silence and withholding of information.
A team of researchers studied the two main viroporins of SARS-CoV-2, namely Orf3a and Envelope (E) protein, from a structural viewpoint.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
A study led by Research Professor Matej Ore-ič from VTT Technical Research Centre of Finland suggests that Alzheimer's disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway.
When you take a medicine you may want the drug to all be released immediately or perhaps more slowly over a longer period of time. If we can make a medicine where we control the release then we can tailor our medicines to release at the exact rate we choose that is best for the patient.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Marie Roebuck, DPT 2142 Eastwood Dr, Fort Collins, CO 80525-2004 Ph: (970) 214-5064 | Jennifer Marie Roebuck, DPT 4016 Laramie St, Cheyenne, WY 82001-2064 Ph: (307) 637-4617 |
News Archive
Injuries and deaths resulting from medical errors can have profound long-term consequences on patients and families. Seriously harmed patients and/or family members who have lost a loved one may describe feelings of neglect, isolation, fear, anger, and despair, among other emotions, many of which can be heightened by organizational silence and withholding of information.
A team of researchers studied the two main viroporins of SARS-CoV-2, namely Orf3a and Envelope (E) protein, from a structural viewpoint.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
A study led by Research Professor Matej Ore-ič from VTT Technical Research Centre of Finland suggests that Alzheimer's disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway.
When you take a medicine you may want the drug to all be released immediately or perhaps more slowly over a longer period of time. If we can make a medicine where we control the release then we can tailor our medicines to release at the exact rate we choose that is best for the patient.
› Verified 3 days ago
Bluegrass Physical Therapy Limited Partnership Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1950 Bluegrass Cir, Suite 110, Cheyenne, WY 82009 Phone: 307-634-2626 Fax: 307-634-5099 | |
Mrs. Linda Rc Froelicher, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4000 Central Ave, Suite #3, Cheyenne, WY 82001 Phone: 307-634-0298 Fax: 307-634-0837 | |
Nicholas Robert Johnson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Converse Ave Ste B, Cheyenne, WY 82001 Phone: 307-514-2411 Fax: 307-514-2392 | |
Byron Louis Long, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1950 Bluegrass Cir, Suite 110, Cheyenne, WY 82009 Phone: 307-634-2626 Fax: 307-634-5099 | |
Mr. Thomas James Bledsoe, M.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4017 Rawlins St, Cheyenne, WY 82001 Phone: 307-635-2562 | |
Sandra Champlin, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1951 Bluegrass Cir, Cheyenne, WY 82009 Phone: 307-773-8533 Fax: 307-635-7578 | |
Dr. Charlene Marie Sheamansmith, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4515 E Pershing Blvd Unit C, Cheyenne, WY 82001 Phone: 307-635-2388 Fax: 307-635-1730 |